We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Chronic lymphocytic/lymphoma panel

General information

Panel of markers used: CD3, CD5, CD19, CD23, CD79b, Kappa chains, Lambda chains, FMC7, CD38 (optional markers: CD10, CD11c, CD25, CD103).

Specimen transport: At room temperature in EDTA tube.

Repeat frequency: Post treatment monitoring, suspected relapse and MRD

Special precautions: Do not refrigerate

Laboratory information

Reporting units: Percentage of the population of cells of interest

Volume and sample type: 5mls EDTA blood or bone marrow

Method: Flow cytometry

Turnaround time (calendar days from sample receipt to authorised result): Median - 2, 95th percentile - 7

Clinical information

Indications for the test: Haematological malignancies involving lymphoid cells

Factors affecting the test: None


Clinical workstation reference: PHENOTYPING


(Last updated October 7th 2014)